Rani Therapeutics Maintained at Buy as Partnerships Highlight Underappreciated Pipeline; $11 Price Target ReaffirmedTip Ranks·Jul 13 at 10:35 AMRANI+1.04%4519
Hong Kong Stock Movement: PEGBIO CO-B falls 10.10%, positive cooperation fails to mask profit concernsHK Stock Alerts·Jul 13 at 02:36 AM02565+1.04%
Hong Kong Stock Movement: PEGBIO CO-B surged 27.49%, partnering with Rani Therapeutics to expand its global GLP-1 layoutHK Stock Alerts·Jul 9 at 09:02 PM02565+1.04%
Hong Kong Stock Movement: PEGBIO CO-B rises 16.82%, deepening international cooperation boosts market confidenceHK Stock Alerts·Jul 9 at 08:37 PM02565+1.04%
PegBio Teams with Rani Therapeutics to Pursue Oral Metabolic TherapiesTip Ranks·Jul 9 at 07:07 PM02565+1.04%RANI+1.04%
Rani Therapeutics partners with PegBio to develop oral obesity drug candidatesPUBT·Jul 9 at 03:11 PMRANI+1.04%02565+1.04%
